Patents by Inventor Christophe Lechauve

Christophe Lechauve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHOD FOR TREATING THALASSEMIA
    Publication number: 20230323348
    Abstract: Methods for removing excess free ?-globin in erythroid cells and treating a thalassemia using a miR-144 and/or miR-451 antagomir are described.
    Type: Application
    Filed: August 19, 2021
    Publication date: October 12, 2023
    Inventors: Mitchell J. WEISS, Christophe LECHAUVE
  • Method for treating thalassemia
    Patent number: 11298343
    Abstract: Methods for removing excess free ?-globin in erythroid cells and treating a thalassemia using an agent that activates Unc-51 Like autophagy activating Kinase (ULK) are described.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: April 12, 2022
    Assignee: ST. JUDE CHILDREN'S RESEARCH HOSPITAL
    Inventors: Mitchell J. Weiss, Mondira Kundu, Christophe Lechauve
  • Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
    Publication number: 20220040333
    Abstract: The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.
    Type: Application
    Filed: July 13, 2021
    Publication date: February 10, 2022
    Inventors: Marisol Corral-Debrinski, Christophe Lechauve, José-Alain Sahel, Thomas Debeir
  • METHOD FOR TREATING THALASSEMIA
    Publication number: 20200345702
    Abstract: Methods for removing excess free ?-globin in erythroid cells and treating a thalassemia using an agent that activates Unc-51 Like autophagy activating Kinase (ULK) are described.
    Type: Application
    Filed: October 26, 2018
    Publication date: November 5, 2020
    Inventors: Mitchell J. Weiss, Mondira Kundu, Christophe Lechauve
  • Use of neuroglobin agonist for preventing or treating mitochondrial RCCI and/or RCCIII deficiency disease
    Publication number: 20150094360
    Abstract: The present invention concerns a neuroglobin agonist for use in the treatment or prevention of a mitochondrial disease associated with respiratory chain complex I (RCCI) deficiency and/or respiratory chain complex III (RCCIII) deficiency.
    Type: Application
    Filed: September 30, 2014
    Publication date: April 2, 2015
    Inventors: Marisol Corral-Debrinski, Christophe Lechauve, José-Alain Sahel, Thomas Debeir